We have investigated the

effects of a water-soluble Zn-phthalocyanine, ZnPc(COONa)(8), a macrocyclic compound with near-infrared optical properties, find more on A fibril formation invitro. A thioflavinT fluorescence assay showed that ZnPc(COONa)(8) significantly inhibited A fibril formation, increasing the lag time and dose-dependently decreasing the plateau level of fibril formation. Moreover, it destabilized pre-formed A fibrils, resulting in an increase in low-molecular-weight species. After fibril formation in the presence of ZnPc(COONa)(8), immunoprecipitation of A(1-42) using A-specific antibody followed by near-infrared scanning demonstrated binding of ZnPc(COONa)(8) to A(1-42). A study using the hydrophobic fluorescent probe 8-anilino-1-naphthalenesulfonic acid showed that ZnPc(COONa)(8) decreased the hydrophobicity during A(1-42) fibril formation. CD spectroscopy showed an increase in the helix structure and a decrease

in the sheet structure of A(1-40) in fibril-forming buffer containing ZnPc(COONa)(8). SDS/PAGE and a dot-blot immunoassay showed that ZnPc(COONa)(8) delayed the disappearance of low-molecular-weight species and the appearance NCT-501 ic50 of higher-molecular-weight oligomeric species of A(1-42). A cell viability assay showed that ZnPc(COONa)(8) was not toxic to a neuronal cell line (A1), but instead protected A1 cells against A(1-42)-induced toxicity. Overall, our results indicate that ZnPc(COONa)(8) binds to A and decreases the hydrophobicity, and this change is unfavorable for A oligomerization and fibril formation.”
“Chronic exposure to arsenic causes a wide range of diseases such as hyperkeratosis, cardiovascular diseases, and skin, lung,

and bladder cancers, and millions of people are chronically exposed to arsenic worldwide. However, little is known about the mechanisms underlying these toxic actions. The metabolism of arsenic is essential for understanding the toxic actions. Here, we identified the major arsenic-binding protein selleck kinase inhibitor (As-BP) in the plasma of rats after oral administration of arsenite by the use of two different HPLC columns, gel filtration and anion exchange ones, coupled with an inductively coupled argon plasma mass spectrometer (ICP MS). The molecular mass of the As-BP was estimated to be 90 kDa based on results using the former column, and arsenic bound to this protein only in the form of dimethylarsinous acid (DMA(III)) in the plasma in vivo. In addition, the purified As-BP was shown to consist of two different proteins, haptoglobin (Hp) of 37 kDa (three bands) and the hemoglobin (Hb) alpha chain of 14 kDa (single band), using sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and matrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS), respectively, suggesting that the As-BP was the ternary DMA(III)-Hb-Hp complex. To confirm the present observations, an arsenic-binding assay was carried out in vitro.